Evidence map›Paper›PMID 38474491›Full record

ArticleMolecules (Basel, Switzerland)2024

Computational Assessment of Spectral Heterogeneity within Fresh Glioblastoma Tissue Using Raman Spectroscopy and Machine Learning Algorithms.

Karoline Klein, Gilbert Georg Klamminger, Laurent Mombaerts, Finn Jelke, Isabel Fernandes Arroteia, Rédouane Slimani, Giulia Mirizzi, Andreas Husch, Katrin B M Frauenknecht, Michel Mittelbronn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Karoline KleinFaculty of Medicine, Saarland University (USAAR), 66424 Homburg, Germany.
Gilbert Georg KlammingerDepartment of General and Special Pathology, Saarland University (USAAR), 66424 Homburg, Germany.ORCID 0000-0001-5358-2751
Laurent MombaertsLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg (UL), 4362 Esch-sur-Alzette, Luxembourg.
Finn JelkeNational Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), 1210 Luxembourg, Luxembourg.
Isabel Fernandes ArroteiaNational Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), 1210 Luxembourg, Luxembourg.ORCID 0000-0002-5424-1198
Rédouane SlimaniDoctoral School in Science and Engineering (DSSE), University of Luxembourg (UL), 4362 Esch-sur-Alzette, Luxembourg.
Giulia MirizziFaculty of Medicine, Saarland University (USAAR), 66424 Homburg, Germany.
Andreas HuschNational Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), 1210 Luxembourg, Luxembourg.ORCID 0000-0001-9404-5127
Katrin B M FrauenknechtNational Center of Pathology (NCP), Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg.ORCID 0000-0002-1372-3297
Michel MittelbronnNational Center of Pathology (NCP), Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg.
Frank HertelFaculty of Medicine, Saarland University (USAAR), 66424 Homburg, Germany.
Felix B Kleine BorgmannFaculty of Medicine, Saarland University (USAAR), 66424 Homburg, Germany.
Centre Hospitalier de Luxembourg · LULaboratoire National de Santé · LUUniversity of Luxembourg · LU

Funding

Luxembourg National Research Fund FNR PEARL P16/BM/11192868
6 · The paper itself

Abstract

Understanding and classifying inherent tumor heterogeneity is a multimodal approach, which can be undertaken at the genetic, biochemical, or morphological level, among others. Optical spectral methods such as Raman spectroscopy aim at rapid and non-destructive tissue analysis, where each spectrum generated reflects the individual molecular composition of an examined spot within a (heterogenous) tissue sample. Using a combination of supervised and unsupervised machine learning methods as well as a solid database of Raman spectra of native glioblastoma samples, we succeed not only in distinguishing explicit tumor areas-vital tumor tissue and necrotic tumor tissue can correctly be predicted with an accuracy of 76%-but also in determining and classifying different spectral entities within the histomorphologically distinct class of vital tumor tissue. Measurements of non-pathological, autoptic brain tissue hereby serve as a healthy control since their respective spectroscopic properties form an individual and reproducible cluster within the spectral heterogeneity of a vital tumor sample. The demonstrated decipherment of a spectral glioblastoma heterogeneity will be valuable, especially in the field of spectroscopically guided surgery to delineate tumor margins and to assist resection control.

Indexed as

Brain NeoplasmsGlioblastomaAlgorithmsHumansMachine LearningSpectrum Analysis, Ramanbrain tumorglioblastomaheterogeneitymachine learningRaman spectroscopyunsupervised learningvibrational spectroscopy

Identifiers

PMID38474491
PMCPMC10935394
OpenAlexW4392110764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.